Karyopharm Therapeutics is a clinical-stage pharmaceutical company, based in Newton, MA, USA, focused on the discovery, development and commercialization of novel, first-in-class agents targeting nuclear transport for the treatment of cancer and other major diseases. Karyopharm is the industry leader in oral Selective Inhibitor of Nuclear Export (SINE) technology, developed to address a central mechanism of oncogenesis via the inhibition of exportins specifically XPO1. Selinexor, Karyopharm’s lead candidate, has been administered to patients with hematologic malignancies or solid tumors in clinical trials worldwide. Karyopharm is currently preparing for its first potential U.S. commercial launch in 2019.
The Manager RN/Patient/Advocacy Marketing is responsible for designing and seeing the successful implementation of the key messages, tactics and relationships associated with the promotion of selinexor on the US market with a specific focus on informing and educating Nurses, Patients and Advocacy groups. This individual will report to the US selinexor Marketing Lead and will work collaboratively with several cross functional partners including: Nurse educator field-based team (CNE), sales, regulatory affairs, medical affairs, HCP/Network marketing, Market Access Hub Team, Advocacy lead, Commercial analytics, legal and others.